VCAM1 and hydrops fetalis: Lemos et al. (23), in a study (Physicians' Health Study, PHS) similar to PRIME, evaluated serum levels of VCAM-1 and ICAM-1, which were compared to controls (474 patients in each group) regarding future coronary events (again not including aspects related to HF as the outcome).